Psychedelics MAPS has immense fundraising success Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction Rowan DunneJuly 4, 2022
Psychedelics Mindset Pharma develops patent-pending new technology Company announces development of novel intranasal formulation with promising efficacy Rowan DunneJune 30, 2022
Alternative Energy Cybin receives FDA approval for new in-human clinical trial Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly Rowan DunneJune 28, 2022
Psychedelics Numinus to offer ketamine-assisted psychotherapy B.C. Mental health care company develops passion inspired by Utah pioneers Rowan DunneJune 27, 2022
Psychedelics HAVN Life to make July appearance on renowned documentary series Biotechnology outfit set to receive attention on American TV this summer Rowan DunneJune 24, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Coming soon PAREA: A new psychedelic-focused alliance of prominent companies with common goals Multi-organization psychedelic partnership set to launch on June 23 Rowan DunneJune 16, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Business Entheon Biomedical hands off DMT clinical study to Cybin Dimethyltryptamine continues to demonstrate tremendous therapeutic potential Rowan DunneJune 14, 2022
Canada Psilocybin and craft cannabis farmers to gather in B.C. Meeting for Vancouver Island growers and community leaders to be held on June 16. Rowan DunneJune 9, 2022